金城医药：子公司产品拟中选第十一批全国药品集中采购

Core Viewpoint - Jincheng Pharmaceutical's subsidiaries participated in the 11th national centralized procurement of drugs, with two products expected to be selected for procurement [1] Group 1: Company Participation - Jincheng Pharmaceutical's wholly-owned subsidiary, Beijing Jincheng Tail Pharmaceutical Co., Ltd., and its controlling subsidiary, Guangdong Jincheng Jinsu Pharmaceutical Co., Ltd., took part in the bidding for the national centralized drug procurement organized by the Joint Procurement Office [1] Group 2: Products Involved - The products involved in the bidding include Jincheng Tail's Ribavirin tablets and Jincheng Jinsu's injectable Cefazolin sodium, which are anticipated to be selected in this centralized procurement [1]